Re: Biogen/Eisai Scrap Aducanumab
in response to
by
posted on
Mar 24, 2019 06:59PM
I can see the reasoning why this is so, its because the placebo group may experience further cognitive deterioration in their MoCA scores whereas the apabetalone group may see an improvement.
Koo